Yahoo Search Busca da Web

Entrar

Resultado da Busca

  1. investors.modernatx.com › news › news-detailsModerna Reports First Quarter 2024 Financial Results and ...

    2 de mai. de 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest ...

  2. investors.modernatx.com › news › news-detailsModerna Announces Data to be Presented at 2024 ASCO Annual ...

    Há 5 dias · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.

  3. g1.globo.com › saude › noticiaPrimeiras doses da vacina Moderna contra a Covid chegam ao ...

    3 de mai. de 2024 · Novo lote de vacinas da Moderna contra a Covid chega ao Brasil. Remessa tem 1,4 milhão de doses. Contrato que prevê 12,5 milhões de doses foi assinado no mês passado.

  4. news.modernatx.com › news › news-detailsModerna Announces Update on Investigational RSV Vaccine

    10 de mai. de 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.

  5. www.nature.com › articles › s41563/024/01867-3Accelerating ionizable lipid discovery for mRNA delivery ...

    13 de mai. de 2024 · Metrics. Abstract. To unlock the full promise of messenger (mRNA) therapies, expanding the toolkit of lipid nanoparticles is paramount. However, a pivotal component of lipid nanoparticle...

  6. finance.yahoo.com › news › moderna-reports-firstModerna Reports First Quarter 2024 Financial Results and ...

    2 de mai. de 2024 · MRNA. Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $ (3.07) Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms...

  7. www.nasdaq.com › market-activity › stocksModerna, Inc. Common Stock (MRNA) - Nasdaq

    10 de mai. de 2024 · Nasdaq 100. Market: Closed. Moderna, Inc. Common Stock ( MRNA ) Volume: 4,238,508. 52 Week Range: 62.55 - 142.79. High/Low: 116.73 - 124.90. Moderna, Inc. Common Stock (MRNA) 1D. 5D. 1M. 6M....